Infantile Myofibromatosis: Causes and Symptoms

Written by Medicover Team and Medically Reviewed by Dr Manish Kumar Kashyap , Pediatric Surgeon

Causes
Find a Doctor
Diagnosis
Treatment
FAQs
Book an Appointment

1. Causes 2. Find a Doctor 3. Diagnosis 4. Treatment 5. FAQs

Infantile myofibromatosis is a rare condition that affects infants, characterized by the growth of tumors in different parts of the body. These tumors are caused by abnormal cell growth within the muscles and fibrous tissues. While the exact cause of infantile myofibromatosis is not fully understood, it is believed to be linked to genetic mutations or alterations that occur during fetal development.

These genetic changes can lead to the uncontrolled growth of cells, forming tumors in various organs or tissues. Understanding the underlying genetic factors contributing to this condition is crucial for developing effective treatment strategies. If your child has been diagnosed with infantile myofibromatosis, your healthcare provider will work closely with you to provide the best possible care and

What Are the Types of Infantile Myofibromatosis?

There are three main types of infantile myofibromatosis: solitary, multicentric, and generalized. Solitary myofibromas present as a single tumor, typically in the skin or soft tissues, and are the most common type. Multicentric myofibromatosis involves the presence of multiple tumors in different areas of the body.

Generalized myofibromatosis is the rarest form and can be more severe, involving widespread tumors affecting various organs and tissues. Each type requires individualized management and monitoring by healthcare providers.

Solitary Infantile Myofibromatosis: Involves a single tumor in a specific location.
Multifocal Infantile Myofibromatosis: Characterized by multiple tumors affecting various parts of the body.
Generalized Infantile Myofibromatosis: Rare and severe form with widespread tumors across the body.
Solitary Congenital Myofibromatosis: Presents as a single tumor at birth.
Fibrous Hamartoma of Infancy: A variant involving fibrous tissue overgrowth in infants.

What Are the Symptoms of Infantile Myofibromatosis?

Symptoms of this condition can vary depending on the location of the tumors within the body. Common signs may include the presence of firm lumps or masses under the skin or in organs, such as the muscles, bones, or intestines.

In some cases, these growths can cause pain, limited movement, or pressure on surrounding tissues. Additionally, infants with myofibromatosis may experience skin discoloration, trouble breathing, or gastrointestinal issues. If your child displays any unusual lumps or symptoms, it is important to consult a healthcare provider for a proper evaluation and management.

Infantile myofibromatosis may present with firm lumps or nodules on the skin or within the body.
Some infants with infantile myofibromatosis may experience respiratory difficulties or obstructive symptoms.
In severe cases, infantile myofibromatosis can lead to organ dysfunction or failure.
Infants affected by myofibromatosis may have restricted movement or stiffness in affected areas.
Skin overlying the myofibromas may appear discolored, reddish, or bluish in hue.

What Causes Infantile Myofibromatosis?

The exact cause of infantile myofibromatosis remains unclear. Researchers believe that genetic mutations affecting connective tissue development play a major role in the abnormal growth of myofibroblast cells.

Genetic mutations are a common cause of Infantile myofibromatosis, impacting the regulation of cell growth and division.
Environmental factors may contribute to Infantile myofibromatosis development, although specific triggers are not yet fully understood.
Family history of the condition can increase the risk of Infantile myofibromatosis in newborns due to inherited genetic predispositions.
Certain syndromes, such as Gorlin syndrome, are associated with a higher likelihood of developing Infantile myofibromatosis.
Sporadic gene mutations can occur, leading to the development of Infantile myofibromatosis, even in the absence of a family history.

When Should You See a Doctor for Infantile Myofibromatosis?

Consult a pediatric surgeon if your child develops unusual lumps, swelling, or symptoms that worsen over time.

Firm lumps or nodules on the skin or soft tissues
Rapidly growing or multiple tumors
Difficulty breathing or swallowing
Feeding problems or persistent vomiting
Pain, restricted movement, or swelling
Signs of organ involvement, such as abdominal swelling or bowel problems

Early diagnosis and timely treatment can help prevent complications and improve long-term outcomes.

Find Pediatric-surgeon for Infantile Myofibromatosis Treatment Near You

How Is Infantile Myofibromatosis Diagnosed?

Following this, imaging studies such as ultrasound, MRI, or CT scans may be conducted to visualize the extent and location of the tumors. A definitive diagnosis often requires a biopsy of the affected tissue for microscopic examination by a pathologist.

Genetic testing may also be recommended to identify any underlying genetic mutations associated with the condition. By combining these diagnostic methods, healthcare professionals can accurately confirm Infantile myofibromatosis and develop an appropriate treatment plan.

Diagnosis of infantile myofibromatosis typically involves a physical examination by a healthcare provider.
Imaging tests such as ultrasound, MRI, or CT scans may be used to visualize the affected areas.
Biopsy of the lesion is often performed to confirm the presence of myofibromatosis.
Genetic testing may be recommended to identify any underlying genetic mutations associated with the condition.

How Is Infantile Myofibromatosis Treated?

Treatment for infantile myofibromatosis depends on the number, size, location, and severity of the tumors, as well as whether internal organs are involved. While some tumors shrink on their own and only require regular monitoring, others may need medical or surgical treatment to prevent complications and improve the child's quality of life.

Treatment options may include:

Observation and regular follow-up for small, asymptomatic tumors that are likely to regress naturally.
Surgical removal of tumors causing pain, functional impairment, or compression of nearby structures.
Medications, such as targeted therapy or chemotherapy, in rare cases with aggressive or life-threatening disease.
Supportive care to manage symptoms and maintain normal growth and development.
Multidisciplinary care involving pediatricians, pediatric surgeons, oncologists, and genetic specialists for complex cases.

Regular follow-up appointments and imaging studies are essential to monitor tumor progression, assess treatment response, and detect any recurrence or complications early.

Your health is everything - prioritize your well-being today.

Consult Infantile Myofibromatosis Doctors Today

What Are the Risk Factors for Infantile Myofibromatosis?

While the exact cause is unknown, certain risk factors have been identified. These include a family history of the disorder, genetic mutations, and abnormalities in certain genes. Premature birth and low birth weight may also increase the likelihood of developing infantile myofibromatosis.

Additionally, there may be a link between the condition and certain maternal health factors during pregnancy. Early detection and proper management are crucial in providing the best possible outcomes for affected children.

Genetic mutations increase the risk of infantile myofibromatosis.
Family history of the condition raises the likelihood of developing infantile myofibromatosis.
Prematurity or low birth weight can be a risk factor for infantile myofibromatosis.
Certain genetic syndromes, such as neurofibromatosis type 1, may predispose individuals to infantile myofibromatosis.
Exposure to certain medications or toxins during pregnancy could potentially increase the risk of infantile myofibromatosis.